CLDN1 and diabetes mellitus: Meanwhile, elevated acetate levels alone may not account for the alleviation of insulin resistance by Kef administration, although previous studies have demonstrated that luminal SCFAs upregulate claudin-1 expression, leading to the restoration of intestinal barrier function and amelioration of insulin resistance in a mouse model of diabetes [44,45,46].